Conference programme

Session labelling: K= Keynote – L= Lay – P = Professional.

Location: K= Norðurljós – L= Edition – P = Norðurljós

Programme (PDF)
Thursday 9 June
RIWC 2022 View NOK 2022 Programme
Hall Norðurljós Björtuloft Eldborg
12:00-13:30
13:30-15:00
15:00-15:30
15:30-17:00
17:30-19:00 NOK and RIWC OPENING CEREMONY @ ELDBORG HARPA.

The President of Iceland, Mr. Guðni Th. Jóhannesson, will open the congress

Keynote: Phenotyping and Genotyping in inherited retinal diseases.
Prof. Bart Leroy from the University of Ghent, Gent, Belgium

Genetics of common diseases, focus on the eye
Speaker: Speaker: Hreinn Stefansson, PhD Head of CNS deCODE genetics
19:00-20:00 GET TOGETHER @ HARPA
Saturday 11 June
RIWC 2022 View NOK 2022 Programme
Hall Norðurljós (Professional) The Reykjavik EDITION (Layman)
08:00-08:30
08:30-10:00 New Developments in IRD.

Moderator:
Professor dr. Michael Larsen
L.3.1 Clinical trials and therapies from a patient’s perspective.
Moderator:
Martin Smedstad, Oslo, Norway.
08:30-08:50 Accessing Genetic Testing for IRDs: The Patient Perspective.

Speaker:
Fiona Waters, Retina International, Dublin, Ireland
08:30 – 08:50 Overview and future on on-going clinical trials

Speaker:
Professor dr. Elise Heon, MD, The Hospital for Sick Children, Toronto, Canada
08:50-09:10 ABCA4 retinal dystrophies

Speaker:
Professor dr. Frans Cremers, Radboud University, Nijmegen, Netherlands
08:50 – 09:10 RPE65 - the first gene therapy on the market

Speaker:
Associate professor dr. Line Kessel, Glostrup, Copenhagen, Denmark
09:10-09:30 PERCEIVE study report: Real-world safety and effectiveness of voretigene neparvovec AND Evaluating a new questionnaire to assess symptoms in RP and LCA

Speaker:
Professor dr. Dominik Fischer, Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom
09:10 – 09:30 Oligonucleotides - a hope for all?

Speaker:
Professor dr. Bart Leroy, Gent University, Ghent, Belgium
09:30-10:00 Medical therapies in IRD

Speaker:
Professor dr. Robert Koenekoop, Montreal Childrens Hospital, Montreal, Canada
09:30 – 09:50 My personal experience of gene therapy

Speaker:
Camilla Jensen, Oslo, Norway
10:00-10:30 Coffee break
10:30-12:00 Stem cells and cell-based therapies of retinal diseases.

Moderator Professor Dr. Goran Petrovski, Oslo, Norway.
L 3.2 Retina International - the global challenges Global Genetic Testing Landscape

Moderator:
Fiona Waters, Retina International, Ireland
10:30 - 10:50 Initiating a Phase I/IIa clinical trial for an autologous iPS cell therapy for macular degeneration: from bench-to-bedside

Speaker:
Dr Kapil Bharti (NIH/NEI), Bethesda, USA
10:30 – 11:15 Impact of age related retinal diseases on society, and calls to action

Speaker:
Nabin Paudel, RI, Ireland Panel Discussion – TBC
10:50 - 11:10 Towards stem cell-based therapy in retinal degeneration.

Speaker:
Professor Dr. Anders Kvanta, Stockholm, Sweden
11:15 – 12:00 Genetic Testing Landscape – a global policy action to support equitable access.

Speaker:
Avril Daly, Retina International, Ireland Panel Discussion - TBC
11:10 – 11:30 Genetically corrected iPS-derived RPE cells for cell therapy of hereditary retinal dystrophy.

Speaker:
Dr. Slaven Erceg, Valencia, Spain
11:30 - 11:50 Subretinal implantation of primary human RPE cells in minipig eyes.

Speaker:
Professor Dr. Goran Petrovski, Oslo, Norway
11:50 - 12:00 Retinal repair by autologous transplantation.

Speaker:
Docent Dr. Xhevat Lumi
12:00-13:00 Lunch
12:30-13:00 Poster viewing
13:00-14:00 Keynote: Gene based therapies of retinal diseases

Speaker: Prof. Artur Cideciyan, University of Pennsylvania, Philadelphia, USA.

Norðurljós Hall
14:00-15:00 Gene based therapies of retinal diseasesModerator: Eeva-Marja Sankila, MD, PhD, Helsinki University Hospital, Helsinki, Finland Programme in islandic for the public.
Stjórnandi: Sigþór U. Hallfreðsson, Félag blindra og sjónskertra, Íslandi
14:00 – 14:15 CPK850 gene therapy in RLPB1 patients.

Speaker: Prof.
Anders Kantar, Karolinska Institute, Stockholm, Sweden
14:00-14:20 Hvað er efst á baugi í rannsóknum og meðferð arfgengra sjónhimnusjúkdóma?

Speaker:
Prófessor dr. Ragnheiður Bragadóttir, Oslo universitetssykehus, Osló, Noregi
14:15 – 14:30 Gene therapy of Choroideraemia and X-linked retinitis pigmentosa - Lessons to be learned

Speaker: Prof.
Professor dr. Robert Koenekoop, Montreal Childrens Hospital, Montreal, Canada
14:20-14:40 Greining og skráning arfgengra sjónhimnusjúkdóma á Íslandi

Speaker:
Prófessor dr. Jón Jóhannes Jónsson, Landspítalinn, Reykjavík
14:30 – 14:45 Retinal gene therapy in choroideremia patients - surgical aspects.

Speaker:
Professor dr. Ilkka Immonen, Helsinki University Hospital, Helsinki, Finland.
14:40-15:00 Hvernig getum við með arfgenga sjónhimnusjúkdóma verið með í rannsóknum?

Speaker:
Helgi Hjörvar, Félag blindra og sjónskertra, Íslandi
14:45 – 15:00 Gene therapy of Usher syndrome.

Speaker:
Professor dr. Isabelle Audo, Institute de la Vision, Paris, France.
15:00-15:15 Þjónusta við blinda og sjónskerta á Íslandi: Notendur á Sjónstöð og algengustu orsakir sjónskerðingar.

Speaker:
Elva Dögg Jóhannesdóttir, Íslandi
15:30 GRAND FINALE AND FUTURE STEPS @ SILFURBERG

Looking to the Future: Care for IRD Patients in the Coming 10 Years
Speaker: Professor dr. Bart Leroy, University of Ghent, Gent, Belgium

Speaker: Professor dr. Einar Stefánsson, University of Iceland, Iceland

Introduction of NOK2024
19:00 Gala Dinner @ Gamla Bíó